Navigation Links
Monogram Announces 2008 Second Quarter Financial Results
Date:7/29/2008

al approach and products by pharmaceutical and biotechnology companies; our estimate of the size of our markets; our estimates of the levels of demand for our products; the impact of competition; the timing and ultimate size of pharmaceutical company clinical trials; whether payers will authorize reimbursement for our products and services and the amount of such reimbursement that may be allowed; whether the FDA or any other agency will decide to further regulate our products or services, including Trofile; whether existing levels of reimbursement will be reviewed and reduced by third party payers, including Medicare; whether the draft guidance on Multivariate Index Assays issued by FDA will be subsequently determined to apply to our current or planned products; whether we will encounter problems or delays in automating our processes; the ultimate validity and enforceability of our patent applications and patents; the possible infringement of the intellectual property of others; whether licenses to third party technology will be available; whether we are able to build brand loyalty and expand revenues; restrictions on the conduct of our business imposed by the Pfizer, G.E. and other debt agreements; the impact of additional dilution if our convertible debt is converted to equity; and whether we will be able to raise sufficient capital in the future, if required. For a discussion of other factors that may cause actual events to differ from those projected, please refer to our most recent annual report on Form 10-K and quarterly reports on Form 10-Q, as well as other subsequent filings with the Securities and Exchange Commission. We do not undertake, and specifically disclaim any obligation, to revise any forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date of such statements.

PhenoSense, PhenoSenseGT, Trofile, HERmark and VeraTag are trademarks of Monogram Biosciences, Inc. Hercept
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Monogram Announces First Medicare Payment for Trofile(TM)
2. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
3. Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
4. Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies
5. Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
9. HEI, Inc. Announces Sale of RFID Division Assets
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... (PRWEB) October 31, 2014 This ... has amazing health effects for practitioners. , ... a Doctor of Science and Movement specializing in ... dedication to pelvic floor reeducation that traditional abdominal ... incontinence, Diastasis Recti, Prolepses, etc. , The Hipopressives ...
(Date:10/31/2014)... News) -- Surgery for low back pain caused by ... States you live, a new report says. "Nearly ... at some point in their lives, and about 30 ... a spine problem," co-author Brook Martin, of the Dartmouth ... a college news release. In spinal stenosis, thickening ...
(Date:10/31/2014)... older Americans say that either they or a family ... to the latest issue of The Gerontological Society of ... PP&AR ), which goes on to show that Americans ... honor patients, end-of-life health care wishes. , This ... Options ," features 12 articles that present new ways ...
(Date:10/31/2014)... October 31, 2014 Urban Hydroponics, Inc. ... today announced it has signed a Binding Letter of ... the urban cultivation sector - Urban Cultivator Inc. (“Urban ... and W3 Metal Inc. (“W3 Metal” and together with ... Pursuant to the LOI and an earlier non-binding ...
(Date:10/31/2014)... Triple Board Certified surgeon Dr. Jeffrey ... transform the appearance of military veteran Joseph Jones. ... Plastic and Reconstruction Surgery (AAFPRS) Faces of Honor program, ... hair Jones lost during an IED blast almost ten ... procedure, valued around $16,000, took Dr. Epstein over eight ...
Breaking Medicine News(10 mins):Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 3Health News:Spinal Surgery Varies by Region in U.S.: Study 2Health News:Advance directives can benefit patients, families, and health care system 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 3Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 4Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 5Health News:Miami Hair Restoration Specialist Transforms Wounded Soldier 2
... doctors,and six others have been charged in four ... schemes totaling $56 million, the Department of,Justice Criminal ... of Florida announced today., One indictment alleges ... Harris, 57, and Enrique Gonzalez, 62, conspired to ...
... hospitals, physicians,pharmaceutical companies, and insurance providers that make ... spending $55 billion on,telecommunications services over the next ... by the Insight Research Corporation. According to,the market ... on,telecommunications services will grow at a compounded rate ...
... 29 GNC wants to help honorably,discharged veterans ... program., The program is designed to help ... next journey in life. Through Dec. 31, 2008, ... normal franchise fee.,Service-disabled veterans receive additional benefits, including ...
... May 29 Alexza,Pharmaceuticals, Inc. (Nasdaq: ... has joined the company as Vice President, ... in the development and,execution of clinical and ... product candidates. Dr. Clarke was most recently,Vice ...
... May 29, 2008 Aging dental bridges are a maintenance headache ... to floss, often decay, and require replacement with longer bridges. ... to nowhere should be replaced with permanent dental implants. ... bridges in our mouths for twenty years or more. They ...
... 2007 ... date in 2008, VANCOUVER, May 29 /PRNewswire-FirstCall/ - CRH Medical ... three months ended March 31, 2008 compared to $0.50 million for ... Company,s net,loss decreased to $0.96 million ($0.02 per share) for the ...
Cached Medicine News:Health News:Three Miami Area Doctors and Six Others Charged in $56 Million Health Care Fraud Schemes 2Health News:Three Miami Area Doctors and Six Others Charged in $56 Million Health Care Fraud Schemes 3Health News:Three Miami Area Doctors and Six Others Charged in $56 Million Health Care Fraud Schemes 4Health News:Three Miami Area Doctors and Six Others Charged in $56 Million Health Care Fraud Schemes 5Health News:Healthcare Industry Spending on Telecommunications Services Hits $55 Billion Over Next Five Years, Says Insight Research 2Health News:Veterans to Receive Business Discounts Through GNC's New Veterans Franchising Opportunity 2Health News:Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations 2Health News:Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations 3Health News:Dental implants preferred option for aging bridges 2Health News:CRH Medical reports Q1 2008 results 2Health News:CRH Medical reports Q1 2008 results 3Health News:CRH Medical reports Q1 2008 results 4
(Date:10/31/2014)... 31, 2014 ThynkWare ( www.thynkware.com ) is ... text and email messages using their thoughts. ... by ThynkWare,s founder, Duane Cash , which is ... This technology allows users to control their devices in ... thought. ThynkWare provides the interface layer between ...
(Date:10/31/2014)... Oct. 30, 2014 Migranade, Inc. announced today ... available to the 36 million U.S. migraine sufferers November, ... that targets the actual cause of migraines and not ... and not the source Migranade is assured to be ... Migraine Relief is available at http://www.migranade.com and ...
(Date:10/31/2014)... 31, 2014  AbbVie (NYSE: ABBV ... quarter ended Sept. 30, 2014. ... our business with double-digit growth from HUMIRA and ... nearly 14 percent in the quarter excluding lipids," ... officer, AbbVie.  "We exceeded our outlook for the ...
Breaking Medicine Technology:ThynkWare Speech Helps Those with ALS and Locked-In Syndrome Translate Thought to Speech on Their Smartphone Devices 2Game Changing Migraine Medication To Be Available November 2014 2AbbVie Reports Third-Quarter 2014 Financial Results 2AbbVie Reports Third-Quarter 2014 Financial Results 3AbbVie Reports Third-Quarter 2014 Financial Results 4AbbVie Reports Third-Quarter 2014 Financial Results 5AbbVie Reports Third-Quarter 2014 Financial Results 6AbbVie Reports Third-Quarter 2014 Financial Results 7AbbVie Reports Third-Quarter 2014 Financial Results 8AbbVie Reports Third-Quarter 2014 Financial Results 9AbbVie Reports Third-Quarter 2014 Financial Results 10AbbVie Reports Third-Quarter 2014 Financial Results 11AbbVie Reports Third-Quarter 2014 Financial Results 12AbbVie Reports Third-Quarter 2014 Financial Results 13AbbVie Reports Third-Quarter 2014 Financial Results 14AbbVie Reports Third-Quarter 2014 Financial Results 15AbbVie Reports Third-Quarter 2014 Financial Results 16AbbVie Reports Third-Quarter 2014 Financial Results 17AbbVie Reports Third-Quarter 2014 Financial Results 18AbbVie Reports Third-Quarter 2014 Financial Results 19AbbVie Reports Third-Quarter 2014 Financial Results 20AbbVie Reports Third-Quarter 2014 Financial Results 21AbbVie Reports Third-Quarter 2014 Financial Results 22AbbVie Reports Third-Quarter 2014 Financial Results 23AbbVie Reports Third-Quarter 2014 Financial Results 24
... WASHINGTON, Sept. 16 Policymakers and market leaders looking for ... are looking to the medical home to advance quickly and ... will converge on Washington, DC, Oct. 21, 2010 to examine ... means to deliver health care with better quality outcomes and ...
... Files New Patent Applications -- SHANGHAI, Sept. 16 /PRNewswire-Asia-FirstCall/ -- ... ... ... first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var ...
Cached Medicine Technology:Patient-Centered Primary Care Collaborative Convenes Annual Summit 2Patient-Centered Primary Care Collaborative Convenes Annual Summit 3China-Biotics Files New Patent Applications 2China-Biotics Files New Patent Applications 3China-Biotics Files New Patent Applications 4China-Biotics Files New Patent Applications 5China-Biotics Files New Patent Applications 6China-Biotics Files New Patent Applications 7
... WaveScan WaveFront System is an ophthalmic diagnostic ... wavefront aberrations of the human eye using ... be used to determine regular (sphero-cylindrical) refractive ... or blurry vision in the human eye. ...
... Trusted technology. Precisely measured. ... precision diagnostics, measuring refractive error ... of the eye. ,As part ... Zyoptix™ Diagnostic Workstation, Zywave II ...
ZYMAR™ ophthalmic solution is an anti-infective prescription eye drop that your doctor may instruct you to use if you have an eye infection caused by bacteria. Bacterial conjunctivitis is the e...
... P.M.® lets you sleep on ... in the morning awake with ... ready to take on the ... comfort and protection, this preservative-free ...
Medicine Products: